Matches 1 - 50 out of 188 1 2 3 4 >


Match Document Document Title
US20140056949 Controlled Release Mucoadhesive Systems  
Formulations for chemoprevention of oral cancer and precancerous lesions, and for methods for preparing the formulations are described.
US20100331187 FORMULATIONS  
The present invention relates to physically stable oil dispersions. It also relates to a method for activating bentones that are designed for use with a low polarity organic systems. It also...
US20130012591 PROPHYLAXIS OF SKIN CANCER WITH RETINAMIDES  
Provided in certain embodiments herein are methods of prophylaxis of skin cancer in individuals having a heightened risk of skin cancer with a fenretinide agent.
US20140155487 METHOD FOR CORRECTING A LIPID IMBALANCE IN A SUBJECT  
The present invention relates to methods for the treatment of a disease or condition associated with lipid imbalance using fenretinide. The invention also relates to diagnostic and screening...
US20120093718 LIPOSOMAL NANOPARTICLES AND OTHER FORMULATIONS OF FENRETINIDE FOR USE IN THERAPY AND DRUG DELIVERY  
Formulations of neutral retinoids, in particular fenretinide (HPR) in the form of lipid nanoparticles, solid dipersions and emulsions are disclosed. These compositions are used to treat diseases...
US20120288568 METHODS AND COMPOSITIONS FOR TREATING OPHTHALMIC CONDITIONS VIA SERUM RETINOL, SERUM RETINOL BINDING PROTEIN (RBP), AND/OR SERUM RETINOL-RBP MODULATION  
Compounds that reduce serum retinol, serum RBP, and/or serum retinol-RBP levels may be used to treat ophthalmic conditions associated with the overproduction of waste products that accumulate...
US20110034554 COMPOSITIONS AND METHODS FOR TREATING MACULAR DEGENERATION  
Methods of retarding formation of a lipofuscin pigment in the retina and of treating or ameliorating the effects of a disease characterized by an accumulation of a lipofuscin pigment in a retina...
US20140323561 Control and repellency of biting flies, house flies, ticks, ants, fleas, biting midges, cockroaches, spiders and stink bugs  
Control and repellency of biting flies, house flies, ticks, ants, fleas, biting midges, cockroaches, spiders and stink bugs is obtained by contact of the insects with at least one of the compounds...
US20140045933 METHODS AND COMPOSITIONS FOR TREATING METABOLIC SYNDROME  
Provided are methods, compositions, systems, and kits for treating metabolic syndrome or a disorder associated with metabolic syndrome, e.g., obesity, dyslipidemia, and/or a diabetic condition,...
US20140302102 COSMETIC COMPOSITION FOR THE LIPS CONTAINING SPHERICAL MICROPARTICLES  
The present invention discloses a cosmetic for the lips comprising spherical micro particles of silica, emollients and gel, as well as cosmetically acceptable excipients. The present invention...
US20150223452 COMPOSITION COMPRISING A PESTICIDAL TERPENE MIXTURE AND A FUNGICIDE  
The present invention relates to a composition comprising a) a pesticidal terpene mixture comprising, as pesticidally active chemical compounds α-terpinene, p-cymene and limonene, and b) at least...
US20140249160 TREATMENT OF HEARING AND BALANCE IMPAIRMENTS WITH REDOX-ACTIVE THERAPEUTICS  
Compositions and methods are provided for prophylactic or therapeutic treatment of a mammal for hearing or balance impairments involving neuronal damage, loss, or degeneration, by administration...
US20050014838 Method for treating vasculature degeneration and stimulating glucose  
A method for treating vascular degeneration and stimulating glucose uptake in diabetics including the administration to a patient of a combination of a dilator of striated muscle microvasculature...
US20110028561 PROTECTION OF NEURAL RETINA BY REDUCTION OF ROD METABOLISM  
Described herein are methods for treatment or prevention of retinal dysfuntion by reduction of rod cell energy demand. Particular embodiments include methods for improving rod-mediated retinal...
US20120283215 PHARMACEUTICAL COMPOSITIONS WHICH INHIBIT FKBP52-MEDIATED REGULATION OF ANDROGEN RECEPTOR FUNCTION AND METHODS OF USING SAME  
Pharmaceutical compositions that bind to a predicted FK506 Binding Protein 52 (FKBP52) interaction surface on the androgen receptor hormone binding domain, otherwise known as FKBP52 Targeting...
US20150139915 METHODS TO DECREASE SUSCEPTIBILITY TO ASTHMATIC BRONCHOCONSTRICTION  
Methods and compositions are described for reducing airway reactivity and the susceptibility to asthmatic bronchoconstriction that involve increasing sphingolipid content in airways and lungs of a...
US20080176945 Carboxilic Acid Amides Provoking A Cooling Sensation  
The present invention refers to cooling compounds of formula I wherein R1, R2, R3, X, Y, Z, and m have the same meaning as given in the specification. The present invention refers furthermore to a...
US20060025477 Analogs of isovaleramide, a pharmaceutical composition including the same, and a method of treating central nervous system conditions or diseases  
An isovaleramide analog having at least one of an increased potency, an increased half-life, and an increased stability compared to isovaleramide. The isovaleramide analog is a cyclic analog or a...
US20110271408 MODIFIED PYR/PYL RECEPTORS ACTIVATED BY ORTHOGONAL LIGANDS  
Mutated PYR/PYL receptor polypeptides and methods of making and using mutated PYR/PYL receptor polypeptides are described.
US20120225871 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY  
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and...
US20120083493 SMALL-MOLECULE MODULATORS OF TRP-P8 ACTIVITY  
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and...
US20080108698 Nutrient Supplement and Use of the Same  
The present invention generally relates to enhancement and recovery of muscle performance in a state of stress induced by physical exercise, disease or trauma. More particularly the invention...
US20130131124 O-CYCLOPROPYLCYCLOHEXYL-CARBOXANILIDES AND THEIR USE AS FUNGICIDES  
The present invention relates to O-CYCLOPROPYLCYCLOHEXYL-CARBOXANILIDES derivatives of formula (I); their process of preparation, their use as fungicide, particularly in the form of fungicide...
US20130136704 P-MENTHANE-3,8-DIOL ISOMER MIXTURE, COMPOSITION COMPRISING THE SAME, AND PRODUCTS COMPRISING THE MIXTURE OR COMPOSITION  
An object of the present invention is to provide a novel technology for preventing crystal precipitation of p-menthane-3,8-diol, and stable products utilizing this technology. Provided is a...
US20120122976 PHOSPHATE-FREE PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF GLAUCOMA  
The invention relates to a phosphate-free pharmaceutical composition which comprises at least one FP prostanoid receptor agonist and/or at least one prostamide receptor agonist and also citrate...
US20130190296 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION  
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Tip-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and...
US20120046359 Bed bug control and repellency  
Control or repellency of bed bugs by bringing the bed bugs into contact with a bed bug control formulation containing at least one compound selected from the group consisting of certain alkyl...
US20110003784 Opsin-binding ligands, compositions and methods of use  
Compounds and compositions of said compounds along with methods of use of compounds are disclosed for treating ophthalmic conditions related to mislocalization of opsin proteins, the misfolding of...
US20120094977 COMPOSITIONS AND METHODS FOR THE TREATMENT OF DISEASE ASSOCIATED WITH TRP-P8 EXPRESSION  
Provided are small-molecule Trp-p8 modulators, including Trp-p8 agonists and Trp-p8 antagonists, and compositions comprising small-molecule Trp-p8 agonists as well as methods for identifying and...
US20080188424 TOPICAL NON-PHARMACEUTICAL COSMETIC, PERSONAL AND PET CARE PRODUCTS WITH CHIRAL TECHNOLOGY AND METHODS OF FORMULATING AND MANUFACTURING THE SAME  
As disclosed herein, a series of compounds that are not generally intended for internalization such as cosmetic, skin and pet care products are formulated using chirally correct ingredients,...
US20140107124 NOVEL PROSTAMIDES FOR THE TREATMENT OF GLAUCOMA AND RELATED DISEASES  
Disclosed herein are compositions comprising an amide related to a prostaglandin and a biogenic amine. Other aspects relate to certain chemical compounds, pharmaceutical compositions, and methods...
US20080103207 TOPICAL CERAMIDE COMPOSITIONS AND METHODS OF USE  
Ceramide NS and butylene glycol can form a topical composition in which the ceramide NS is lamellar. The topical compositions can be used in a formulation such as a lotion, gel, or cream and can...
US20090035302 Rage Antagonists As Agents To Reverse Amyloidosis And Diseases Associated Therewith  
Disclosed are RAGE antagonist compounds that have the ability to reverse pre-existing amyloidosis. Treatment with the RAGE antagonist compounds described herein may be used to reduce plaque size...
US20150133546 SUSTAINED RELEASE DELIVERY OF ONE OR MORE AGENTS  
The lacrimal implant delivery systems and methods described herein provide for controlled release of a therapeutic agent for the treatment of disease, including the treatment of glaucoma, ocular...
US20150111969 J-SERIES PROSTAGLANDIN-ETHANOLAMIDES AS NOVEL THERAPEUTICS  
Provided is a compound of formula (I): a pharmaceutical composition comprising the compound of formula (I), a pharmaceutical composition comprising anandamide (AEA) and methods of using the same...
US20120052120 NANOTECHNOLOGY FORMULATION OF POORLY SOLUBLE COMPOUNDS  
Embodiments of the present invention are directed to articles of manufacture, spheres having a diameter of 50 to 500 nanometers which contain poorly soluble drugs and methods of making such...
US20140044737 RBP4 IN INSULIN SENSITIVITY/RESISTANCE, DIABETES, AND OBESITY  
Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of...
US20120295950 RBP4 IN INSULIN SENSITIVITY/RESISTANCE, DIABETES, AND OBESITY  
Methods for screening molecules that modulate the activity of Retinol Binding Protein 4 (RBP4) and their use in treatment of insulin resistance are described. Also described are methods of...
US20090098173 TOPICAL PAIN RELIEF PRODUCT  
The present invention is directed to a topical composition comprising a counterirritant active ingredient and a sensate that provides a cooling sensation to the skin that is topically perceptible...
US20150126437 METHODS FOR ASSESSING REPELLANT QUALITY OF ORGANIC MATERIALS AND METHODS AND COMPOSITIONS FOR REPELLING ARTHROPODS  
The disclosure provides compounds useful as insect repellents, compositions comprising such repellents, and methods of repelling an arthropod using such compounds and compositions. The disclosure...
US20060270737 Menthol propyleneglycol-carbonate and analogs thereof as insect pest repellents  
Menthol propyleneglycol-carbonate, analogs thereof and compositions containing such compounds are useful as insect repellents.
US20070004620 Fp receptor antagonists or pgf2 alpha antagonists for treating pathological conditions of the uterus  
A method of treating or preventing a pathological condition of the uterus in an female individual, the method comprising administering to the individual at least one agent that prevents PGF2α,...
US20120088745 CHEMICALLY MODIFIED SMALL MOLECULES  
Methods of modifying the rate of systemic absorption of a drug administered to a subject by a pulmonary route, the method comprising covalently conjugating a hydrophilic polymer to a drug, wherein...
US20110077298 Retinoid Derivative and Pharmaceutical Composition and Use Thereof  
The invention relates to a retinoid derivative and pharmaceutical composition and use thereof. The compound of the invention is capable of preventing or treating hematological tumours, such as...
US20100076080 Synthesis of Cyclohexane Derivatives Useful as Sensates in Consumer Products  
The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those...
US20130289034 4-(p-QUINONYL)-2-HYDROXYBUTANAMIDE DERIVATIVES FOR TREATMENT OF MITOCHONDRIAL DISEASES  
Methods of treating or suppressing mitochondrial diseases, such as Friedreich's ataxia (FRDA), Leber's Hereditary Optic Neuropathy (LHON), mitochondrial myopathy, encephalopathy, lactacidosis, and...
US20130303473 LIQUID PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF A POSTERIOR EYE DISEASE  
The invention provides pharmaceutical compositions based on liquid vehicles whose density is substantially higher than that of aqueous physiological fluids. The compositions are useful as...
US20050261302 Inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme and their therapeutic application  
The present invention relates to the use of inhibitors of the 11-beta-hydroxysteroid dehydrogenase Type 1 enzyme. The present invention further relates to the use of inhibitors of...
US20120309835 METHODS, ASSAYS AND COMPOSITIONS FOR TREATING RETINOL-RELATED DISEASES  
Described herein are methods and compositions for treating certain retinol-related diseases and conditions by modulation of transthyretin (TTR) and retinol binding protein (RBP) availability in...
US20100022997 Method and process for producing youthful-appearing, small-pored, and smooth skin  
The method and process for producing youthful appearing, small-pored, and smooth skin comprises pre-treating the skin topically with retinoic acid, applying a contaminant in oil to the skin, and...

Matches 1 - 50 out of 188 1 2 3 4 >